Kerman University of Medical SciencesInternational Journal of Health Policy and Management2322-59397320180301BRIC Health Systems and Big Pharma: A Challenge for Health Policy and Management201206344910.15171/ijhpm.2017.145ENVictor G.RodwinRobert F. Wagner Graduate School of Public Service, New York University,
New York City, NY, USAGuilhemFabreUniversité Paul Valéry Montpellier 3, IRIEC EA 740,
Montpellier, FranceRafael F.AyoubWagner School of Public Service, NewYork University,
New York City, NY, USAJournal Article20171022<span class="fontstyle0">BRIC nations – Brazil, Russia, India, and China – represent 40% of the world’s population, including a growing aging population and middle class with an increasing prevalence of chronic disease. Their healthcare systems increasingly rely on prescription drugs, but they differ from most other healthcare systems because healthcare expenditures in BRIC nations have exhibited the highest revenue growth rates for pharmaceutical multinational corporations (MNCs), Big Pharma. The response of BRIC nations to Big Pharma presents contrasting cases of how governments manage the tensions posed by rising public expectations and limited resources to satisfy them. Understanding these tensions represents an emerging area of research and an important challenge for all those who work in the field of health policy and management (HPAM).</span>https://www.ijhpm.com/article_3449_a783bb23102ec29f14a05677559d9cc8.pdfKerman University of Medical SciencesInternational Journal of Health Policy and Management2322-59397320180301The Urgency to Mitigate the Spread of Hepatitis C in Pakistan Through Blood Transfusion Reform207209342610.15171/ijhpm.2017.120ENKamiarAlaeiDepartment of Public Administration and Policy, Rockefeller College, University
at Albany, Albany, NY, USAGlobal Institute for Health and Human Rights
(GIHHR), University at Albany, Albany, NY, USADepartment of Health Policy,
Management and Behavior, School of Public Health, University at Albany,
Albany, NY, USAMohammadSarwarDepartment of Public Administration and Policy, Rockefeller College, University
at Albany, Albany, NY, USAGlobal Institute for Health and Human Rights
(GIHHR), University at Albany, Albany, NY, USAArashAlaeiGlobal Institute for Health and Human Rights
(GIHHR), University at Albany, Albany, NY, USADepartment of Health Policy,
Management and Behavior, School of Public Health, University at Albany,
Albany, NY, USAJournal Article20170407<span class="fontstyle0">Blood transfusions are contributing to a higher rate of hepatitis C virus (HCV) in Pakistan. Half of all blood transfusions in Pakistan are not screened for hepatitis C, hepatitis B or HIV. Family members donate blood that is likely not tested due to social stigma attached to HCV. Paid donations are also quite common in the country, especially by people who inject drugs (PWID), which increases the population’s exposure to HCV. Most of the population utilizes the private sector for their health needs; this sector has lax regulation due to the lack of oversight by the government or any other regulatory body. In addition, groups who are at most need for blood transfusions, such as hemophiliacs and those with thalassemia, have a higher rate of hepatitis C. This fact reinforces the need for blood transfusion reform in Pakistan, which includes improving oversight, upgrading infrastructure and promoting health literacy through cultural norms, according to the World Health Organization (WHO) recommendations. The lessons learned in Pakistan can be adapted to countries facing similar issues.</span>https://www.ijhpm.com/article_3426_5238be33a42b92c00fba720969b5d2b6.pdfKerman University of Medical SciencesInternational Journal of Health Policy and Management2322-59397320180301Human Dignity as Leading Principle in Public Health Ethics: A Multi-Case Analysis of 21st Century German Health Policy Decisions210224337410.15171/ijhpm.2017.67ENSebastian F.WinterFaculty of Medicine, Charité - University Medicine Berlin, Berlin, GermanyStefan F.WinterCentre for Public Health Care, Hannover Medical School, Hanover, GermanyJournal Article20161223Background<br /> There is ample evidence that since the turn of the millennium German health policy made a considerable step towards prevention and health promotion, putting the strategies of ‘personal empowerment’ and ‘settings based approach’ high on the federal government’s agenda. This phenomenon has challenged the role of ethics in health policy. Concurrently, increasing relevance of the <em>Concept of Human Dignity </em>for health and human rights has been discussed. However, a direct relationship between Human Dignity and Public Health Ethics (PHE) has surprisingly not yet been established. <br /> <br /> Methods<br /> We here conduct a systematic ethical analysis of eminent German health prevention policy case-examples between the years 2000–2016. Specifically, our analysis seeks to adapt and apply the principalism (autonomy, beneficence, justice)-based <em>Concept of Human Dignity </em>of Italian philosopher Corrado Viafora, contextualizing it with the emerging field of PHE. To further inform this health policy analysis, index databases (PubMed, Google Scholar) were searched to include relevant published and grey literature. <br /> <br /> Results<br /> We observe a systematic approach of post-millennial health policy decisions on prevention and on defined health targets in Germany, exemplified by (1) the fostering of the preparedness against pandemic infectious diseases, (2) the development and implementation of the first cancer vaccination, (3) major legal provisions on non-smokers protection in the public domain, (4) acts to strengthen long term care (LTC) as well as (5) the new German E-Health legislation. The ethical analysis of these health prevention decisions exhibits their profound ongoing impact on social justice, probing their ability to meet the underlying <em>Concept of Human Dignity </em>in order to fulfill the requirements of the principle of non-maleficence. <br /> <br /> Conclusion<br /> The observed health policy focus on prevention and health promotion has sparked new public debates about the formation of/compliance with emerging standards of PHE in Germany. We believe that the overall impact of this novel policy orientation will gradually show over mid- and long-term periods, both in terms of improvements in health system performance and concurrently in diagnostics, therapies and health outcome on individual patient level. The <em>Concept of Human Dignity</em> may soon play an even greater role in European PHE debates to come.https://www.ijhpm.com/article_3374_182c4ee6cc38b51b855bd850e6829b3c.pdfKerman University of Medical SciencesInternational Journal of Health Policy and Management2322-59397320180301Prevalence of HAV Ab, HEV (IgG), HSV2 IgG, and Syphilis Among Sheltered Homeless Adults in Tehran, 2012225230338410.15171/ijhpm.2017.74ENFatemehJahanbakhashVirology Research Group, Pasteur institute of Iran, Tehran, IranFahimehBagheri AmiriUrology and
Nephrology Research Center, Shahid Beheshti University of Medical Sciences,
Tehran, IranAbbasSedaghatBlood Transfusion Research Center, High Institute for Research
and Education in Transfusion Medicine, Tehran, IranCenter for Disease
Control, Ministry of Health and Medical Education, Tehran, IranNoushinFahimfarDepartment
of Epidemiology and Biostatistics, School of Public Health, Tehran University
of Medical Sciences, Tehran, IranHIV/STI Surveillance Research Center, and
WHO Collaborating Center for HIV Surveillance Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran0000-0001-6205-9794EhsanMostafaviDepartment of
Epidemiology and Biostatistics, Research Centre for Emerging and Reemerging
Infectious Diseases, Pasteur Institute of Iran, Tehran, IranHIV/STI Surveillance Research Center, and
WHO Collaborating Center for HIV Surveillance Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran0000-0002-1997-517XJournal Article20160919Background <br />This study investigated the prevalence for hepatitis A virus (HAV), hepatitis E virus (HEV), herpes simplex virus type 2 (HSV2) and syphilis among homeless in the city of Tehran. <br /> <br />Methods <br />In this cross-sectional study, 596 homeless were recruited in Tehran. A researcher-designed questionnaire was used to study demographic data. Using enzyme-linked immunoassay, and rapid plasma reagin (RPR) test, we evaluated the seroprevalence of HAV anti-body, HEV IgG, herpes, HSV2 IgG, and syphilis among sheltered homeless in Tehran. The associations between the participant’s characteristics and infections were evaluated using logistic regression and chi-square. <br /> <br />Results <br />A total of 569 homeless, 78 women (13.7%) and 491 men (86.3%) were enrolled into the study from June to August 2012. Their age mean was 42 years and meantime of being homeless was 24 months. Seroprevalence of syphilis, HEV IgG, HSV2 IgG and HAV Ab was 0.55%, 24.37%, 16.48%, and 94.34%, respectively. History of drug abuse was reported in 77.70%; 46.01% of them were using a drug during the study and 26.87% of them had history of intravenous drug abuse. Among people who had intravenous drug abuse, 48.25% had history of syringe sharing. <br /> <br />Conclusion <br />The prevalence of HAV, HEV and HSV2 were higher than the general population while low prevalence of syphilis was seen among homeless peoples who are at high risk of sexually transmitted infection (STD). Our findings highlighted that significant healthcare needs of sheltered homeless people in Tehran are unmet and much more attention needs to be paid for the health of homeless people.https://www.ijhpm.com/article_3384_25777ec3f83188a313a3b22b8970da65.pdfKerman University of Medical SciencesInternational Journal of Health Policy and Management2322-59397320180301Using Complexity and Network Concepts to Inform Healthcare Knowledge Translation231243338510.15171/ijhpm.2017.79ENAlisonKitsonAdelaide Nursing School, Faculty of Health and Medical Sciences, University
of Adelaide, Adelaide, SA, AustraliaGreen Templeton College, University of
Oxford, Oxford, UK0000-0003-3053-8381AlanBrookAdelaide Dental School, Faculty of Health and Medical
Sciences, University of Adelaide, Adelaide, SA, AustraliaInstitute of Dentistry,
Queen Mary University of London, London, UKGillHarveyAdelaide Nursing School, Faculty of Health and Medical Sciences, University
of Adelaide, Adelaide, SA, AustraliaAlliance Manchester Business
School, University of Manchester, Manchester, UK0000-0003-0937-7819ZoeJordanFaculty of Health and
Medical Sciences, The Joanna Briggs Institute, University of Adelaide,
Adelaide, SA, AustraliaRhianonMarshallAdelaide Nursing School, Faculty of Health and Medical Sciences, University
of Adelaide, Adelaide, SA, AustraliaRebekahO’SheaAdelaide Nursing School, Faculty of Health and Medical Sciences, University
of Adelaide, Adelaide, SA, AustraliaDavidWilsonAdelaide Medical School, Faculty of Health and
Medical Sciences, University of Adelaide, Adelaide, SA, AustraliaJournal Article20160311<span>Many representations of the movement of healthcare knowledge through society exist, and multiple models for the <span>translation of evidence into policy and practice have been articulated. Most are linear or cyclical and very few come close <span>to reflecting the dense and intricate relationships, systems and politics of organizations and the processes required to <span>enact sustainable improvements. We illustrate how using complexity and network concepts can better inform knowledge <span>translation (KT) and argue that changing the way we think and talk about KT could enhance the creation and movement <span>of knowledge throughout those systems needing to develop and utilise it. From our theoretical refinement, we propose <span>that KT is a complex network composed of five interdependent sub-networks, or clusters, of key processes (problem <span>identification [PI], knowledge creation [KC], knowledge synthesis [KS], implementation [I], and evaluation [E]) that <span>interact dynamically in different ways at different times across one or more sectors (community; health; government; <span>education; research for example). We call this the KT Complexity Network, defined as a network that optimises the <span>effective, appropriate and timely creation and movement of knowledge to those who need it in order to improve what <span>they do. Activation within and throughout any one of these processes and systems depends upon the agents promoting <span>the change, successfully working across and between multiple systems and clusters. The case is presented for moving to <span>a way of thinking about KT using complexity and network concepts. This extends the thinking that is developing around <span>integrated KT approaches. There are a number of policy and practice implications that need to be considered in light of <span>this shift in thinking.</span></span></span></span></span></span></span></span></span></span></span></span></span></span></span><br /></span>https://www.ijhpm.com/article_3385_85c937ce3180c119b6f1de73c7e99d7b.pdfKerman University of Medical SciencesInternational Journal of Health Policy and Management2322-59397320180301A Critical Analysis of Purchasing Arrangements in Kenya: The Case of the National Hospital Insurance Fund244254339110.15171/ijhpm.2017.81ENKennethMungeHealth Economics Research Unit, KEMRI Wellcome Trust Research
Programme, Nairobi, KenyaStephenMulupiHealth Economics Research Unit, KEMRI Wellcome Trust Research
Programme, Nairobi, KenyaEdwine W.BarasaHealth Economics Research Unit, KEMRI Wellcome Trust Research
Programme, Nairobi, Kenya0000-0001-5793-7177JaneChumaHealth Economics Research Unit, KEMRI Wellcome Trust Research
Programme, Nairobi, KenyaKenya Country Office, The World Bank, Nairobi,
KenyaJournal Article20170126Background<br /> Purchasing refers to the process by which pooled funds are paid to providers in order to deliver a set of health care interventions. Very little is known about purchasing arrangements in low- and middle-income countries (LMICs), and certainly not in Kenya. This study aimed to critically analyse purchasing arrangements in Kenya, using the National Hospital Insurance Fund (NHIF) as a case study.<br /> <br /> Methods<br /> We applied a principal-agent relationship framework, which identifies three pairs of principal-agent relationships (government-purchaser, purchaser-provider, and citizen-purchaser) and specific actions required within them to achieve strategic purchasing. A qualitative case study approach was applied. Data were collected through document reviews (statutes, policy and regulatory documents) and in-depth interviews (n = 62) with key informants including NHIF officials, Ministry of Health (MoH) officials, insurance industry actors, and health service providers. Documents were summarised using standardised forms. Interviews were recorded, transcribed verbatim, and analysed using a thematic framework approach.<br /> <br /> Results<br /> The regulatory and policy framework for strategic purchasing in Kenya was weak and there was no clear accountability mechanism between the NHIF and the MoH. Accountability mechanisms within the NHIF have developed over time, but these emphasized financial performance over other aspects of purchasing. The processes for contracting, monitoring, and paying providers do not promote equity, quality, and efficiency. This was partly due to geographical distribution of providers, but also due to limited capacity within the NHIF. There are some mechanisms for assessing needs, preferences, and values to inform design of the benefit package, and while channels to engage beneficiaries exist, they do not always function appropriately and awareness of these channels to the beneficiaries is limited. <br /> <br /> Conclusion<br /> Addressing the gaps in the NHIF’s purchasing performance requires a number of approaches. Critically, there is a need for the government through the MoH to embrace its stewardship role in health, while recognizing the multiplicity of actors given Kenya’s devolved context. Relatively recent decentralisation reforms present an opportunity that should be grasped to rewrite the contract between the government, the NHIF and Kenyans in the pursuit of universal health coverage (UHC).https://www.ijhpm.com/article_3391_2af4beb15aeba71b26a74ff7603df858.pdfKerman University of Medical SciencesInternational Journal of Health Policy and Management2322-59397320180301Comparing the Income Elasticity of Health Spending in Middle-Income and High-Income Countries: The Role of Financial Protection255263339210.15171/ijhpm.2017.83ENArturo VargasBustamanteDepartment of Health Policy and Management, Fielding School of Public
Health, University of California, Los Angeles, CA, USASandhya V.ShimogaDepartment of Health
Care Administration, California State University, Long Beach, CA, USAJournal Article20160831Background<br /> As middle-income countries become more affluent, economically sophisticated and productive, health expenditure patterns are likely to change. Other socio-demographic and political changes that accompany rapid economic growth are also likely to influence health spending and financial protection.<br /> <br /> Methods<br /> This study investigates the relationship between growth on per-capita healthcare expenditure and gross domestic product (GDP) in a group of 27 large middle-income economies and compares findings with those of 24 high-income economies from the Organization for Economic Cooperation and Development (OECD) group. This comparison uses national accounts data from 1995-2014. We hypothesize that the aggregated income elasticity of health expenditure in middle-income countries would be less than one (meaning healthcare is a normal good). An initial exploratory analysis tests between fixed-effects and random-effects model specifications. A fixed-effects model with time-fixed effects is implemented to assess the relationship between the two measures. Unit root, Hausman and serial correlation tests are conducted to determine model fit. Additional explanatory variables are introduced in different model specifications to test the robustness of our regression results. We include the out-of-pocket (OOP) share of health spending in each model to study the potential role of financial protection in our sample of high- and middle-income countries. The first-difference of study variables is implemented to address non-stationarity and cointegration properties.<br /> <br /> Results<br /> The elasticity of per-capita health expenditure and GDP growth is positive and statistically significant among sampled middle-income countries (51 per unit-growth in GDP) and high-income countries (50 per unit-growth in GDP). In contrast with previous research that has found that income elasticity of health spending in middle-income countries is larger than in high-income countries, our findings show that elasticity estimates can change if different criteria are used to assemble a more homogenous group of middle-income countries. Financial protection differences between middle- and high-income countries, however, are not associated with their respective income elasticity of health spending. `<br /> <br /> Conclusion<br /> The study findings show that in spite of the rapid economic growth experienced by the sampled middleincome countries, the aggregated income elasticity of health expenditure in them is less than one, and equals that of high-income countries.https://www.ijhpm.com/article_3392_439b85635d5583d4afa7aa4eacb26005.pdfKerman University of Medical SciencesInternational Journal of Health Policy and Management2322-59397320180301Adopting New International Health Instruments – What Can We Learn From the FCTC?; Comment on “The Legal Strength of International Health Instruments - What It Brings to Global Health Governance?”264267338710.15171/ijhpm.2017.78ENMarliesHesselmanDepartment of International Law/Global Health Law Groningen, Faculty of
Law, University of Groningen, Groningen, The NetherlandsBrigitToebesGlobal Health
Law Groningen Research Centre, Faculty of Law, University of Groningen,
Groningen, The Netherlands0000-0003-0503-2004Journal Article20170415This Commentary forms a response to Nikogosian’s and Kickbusch’s forward-looking perspective about the legal strength of international health instruments. Building on their arguments, in this commentary we consider what we can learn from the Framework Convention on Tobacco Control (FCTC) for the adoption of new legal international health instruments.https://www.ijhpm.com/article_3387_12454337ce4751a74ab5bec551ae7a89.pdfKerman University of Medical SciencesInternational Journal of Health Policy and Management2322-59397320180301Populism, Exclusion, Post-truth. Some Conceptual Caveats; Comment on “The Rise of Post-truth Populism in Pluralist Liberal Democracies: Challenges for Health Policy”268271338810.15171/ijhpm.2017.80ENBenjaminDe CleenDepartment of Communication Studies, Vrije Universiteit Brussel-VUB, Brussels, BelgiumCenter for Media Data and Society, and Political
Science Department, Central European University, Budapest, HungaryJournal Article20170422In their editorial, Speed and Mannion identify two main challenges “the rise of post-truth populism” poses for health policy: the populist threat to inclusive healthcare policies, and the populist threat to well-designed health policies that draw on professional expertise and research evidence. This short comment suggests some conceptual clarifications that might help in thinking through more profoundly these two important issues. It argues that we should approach right-wing populism as a combination of a populist down/up (people/elite) axis with an exclusionary nationalist in/out (member/non-member) axis. And it raises some questions regarding the equation between populism, demagogy and the rejection of expertise and scientific knowledge.https://www.ijhpm.com/article_3388_747b06e54d170f25d164f9bd89f760da.pdfKerman University of Medical SciencesInternational Journal of Health Policy and Management2322-59397320180301Toward Customized Care; Comment on “(Re) Making the Procrustean Bed? Standardization and Customization as Competing Logics in Healthcare”272274338910.15171/ijhpm.2017.84ENEtienneMinvielleEcole des hautes études en santé publique (EHESP), Institut Gustave Roussy, Villejuif, FranceJournal Article20170617Patients want their personal needs to be taken into account. Accordingly, the management of care has long involved some degree of personalization. In recent times, patients’ wishes have become more pressing in a moving context. As the population ages, the number of patients requiring sophisticated combinations of longterm care is rising. Moreover, we are witnessing previously unvoiced demands, preferences and expectations (eg, demand for information about treatment, for care complying with religious practices, or for choice of appointment dates). In view of the escalating costs and the concerns about quality of care, the time has now come to rethink healthcare delivery. Part of this reorganization can be related to customization: what is needed is a customized business model that is effective and sustainable. Such business model exists in different service sectors, the customization being defined as the development of tailored services to meet consumers’ diverse and changing needs at near mass production prices. Therefore, its application to the healthcare sector needs to be seriously considered.https://www.ijhpm.com/article_3389_1ec958d247c3409627966da180d12bfc.pdfKerman University of Medical SciencesInternational Journal of Health Policy and Management2322-59397320180301State Support: A Prerequisite for Global Health Network Effectiveness; Comment on “Four Challenges that Global Health Networks Face”275277339410.15171/ijhpm.2017.86ENRobertMartenFaculty of Public Health and Policy, London School of Hygiene and Tropical Medicine, London, UKhttps://orcid.org/00Richard D.SmithFaculty of Public Health and Policy, London School of Hygiene and Tropical Medicine, London, UKJournal Article20170517Shiffman recently summarized lessons for network effectiveness from an impressive collection of case-studies. However, in common with most global health governance analysis in recent years, Shiffman underplays the important role of states in these global networks. As the body which decides and signs international agreements, often provides the resourcing, and is responsible for implementing initiatives all contributing to the prioritization of certain issues over others, state recognition and support is a prerequisite to enabling and determining global health networks’ success. The role of states deserves greater attention, analysis and consideration. We reflect upon the underappreciated role of the state within the current discourse on global health. We present the tobacco case study to illustrate the decisive role of states in determining progress for global health networks, and highlight how states use a legitimacy loop to gain legitimacy from and provide legitimacy to global health networks. Moving forward in assessing global health networks’ effectiveness, further investigating state support as a determinant of success will be critical. Understanding how global health networks and states interact and evolve to shape and support their respective interests should be a focus for future research.https://www.ijhpm.com/article_3394_d91d094ed4cfba84ecad982f695d106a.pdfKerman University of Medical SciencesInternational Journal of Health Policy and Management2322-59397320180301Health Services Research Spending and Healthcare System Impact; Comment on “Public Spending on Health Service and Policy Research in Canada, the United Kingdom, and the United States: A Modest Proposal”278281339910.15171/ijhpm.2017.92ENMorris L.BarerCentre for Health Services and Policy Research and School of Population and
Public Health, University of British Columbia, Vancouver, BC, CanadaStirlingBryanCentre
for Clinical Epidemiology & Evaluation and School of Population and Public
Health, University of British Columbia, Vancouver, BC, CanadaJournal Article20170625The challenges associated with translating health services and policy research (HSPR) evidence into practice are many and long-standing. Indeed, those challenges have themselves spawned new areas of research, including knowledge translation and implementation science. These sub-disciplines have increased our understanding of the critical success factors associated with the uptake of research evidence into (system) practice. Engaging those for whom research evidence is likely to help solve implementation and/or policy problems, and ensuring that they are key partners throughout the research life-cycle, appear to us (based on current evidence) to be the most direct and effective paths to improved knowledge translation. In that regard, building on Canada’s recent Strategy for Patient Oriented Research (SPOR) would seem to offer considerable promise. The “modest” proposals offered by Thakkar and Sullivan seem less likely to bear fruit.https://www.ijhpm.com/article_3399_d550552a3615d6faa97066ad4e02072b.pdfKerman University of Medical SciencesInternational Journal of Health Policy and Management2322-59397320180301Challenges Facing Global Health Networks: The NCD Alliance Experience; Comment on “Four Challenges that Global Health Networks Face”282285340010.15171/ijhpm.2017.93ENKatieDainThe NCD Alliance, Geneva, SwitzerlandJournal Article20170613Successful prevention and control of the epidemic of noncommunicable diseases (NCDs) cannot be achieved by the health sector alone: a wide range of organisations from multiple sectors and across government must also be involved. This requires a new, inclusive approach to advocacy and to coordinating, convening and catalysing action across civil society, best achieved by a broad-based network. This comment maps the experience of the NCD Alliance (NCDA) on to Shiffman’s challenges for global health networks – framing (problem definition and positioning), coalition-building and governance – and highlights some further areas overlooked in his analysis.https://www.ijhpm.com/article_3400_b9e6e4a03b6b0c64f547802ee5462d97.pdfKerman University of Medical SciencesInternational Journal of Health Policy and Management2322-59397320180301Why Learning How to Chase Butterflies Matters: A Response to Recent Commentaries286287342010.15171/ijhpm.2017.114ENPascaleLehouxDepartment of Health Management, Evaluation and Policy, School of Public
Health, University of Montreal, Montréal, QC, CanadaInstitute of Public Health
Research of University of Montreal (IRSPUM), Montréal, QC, Canada0000-0001-9482-1800Fiona A.MillerInstitute
of Health Policy, Management and Evaluation, University of Toronto, Toronto,
ON, CanadaGenevièveDaudelinInstitute of Public Health
Research of University of Montreal (IRSPUM), Montréal, QC, CanadaJean-LouisDenisDepartment of Health Management, Evaluation and Policy, School of Public
Health, University of Montreal, Montréal, QC, Canada0000-0003-1295-332XJournal Article20170906https://www.ijhpm.com/article_3420_ac00a6635b9419376f0b0f30a7c01ad0.pdfKerman University of Medical SciencesInternational Journal of Health Policy and Management2322-59397320180301How Political Science Can Contribute to Public Health: A Response to Gagnon and Colleagues288289341110.15171/ijhpm.2017.103ENAnitaKothariSchool of Health Studies, Faculty of Health Sciences, Western University,
London, ON, Canada0000-0003-1533-6976RutaValaitisSchool of Nursing, McMaster University, Hamilton,
ON, Canada0000-0002-3117-0542VeraEtchesOttawa Public Health, Ottawa, ON, CanadaMarcLefebvreSudbury & District
Health Unit, Sudbury, ON, CanadaCalMartellChamplain LHIN, Ottawa, ON, CanadaSinéadMcElhonePublic Health Department-Niagara Region, Niagara, ON, CanadaRuthSandersonOxford
County Public Health, Woodstock, ON, CanadaLouiseSimmonsEastern Ontario Health Unit,
Cornwall, ON, CanadaJournal Article20170816https://www.ijhpm.com/article_3411_e185201fbbd4c5b8b9ccfd4afc4be770.pdf